Tekeli Taşkömür, A., Erten, Özlem and Dilbaz, B. 2021. Comparison of two drospirenone-containing oral contraceptives for their effect on the ovary, menstrual cycle, acne, and side-effect profile: 20 µg ethinylestradiol/3 mg drospirenone (24/4) versus 30 µg ethinylestradiol/3 mg drospirenone (21/7). Journal of Surgery and Medicine. 5, 11 (Nov. 2021), 1099–1103. DOI:https://doi.org/10.28982/josam.1002126.